A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
The overexpression of the A(3) adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in the search for new A(3)AR ligands, a series of novel 2,N(6)-disubstituted adenosines (Ados) was synthesized and tested in radioligand bindi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879107/ https://www.ncbi.nlm.nih.gov/pubmed/35215276 http://dx.doi.org/10.3390/ph15020164 |